Skip to main content
HR 2843 117th Congress House

STOP GAMES Act of 2021

Official title: To amend subsection (q) of section 505 of the Federal Food, Drug, and Cosmetic Act to clarify the process for denying certain petitions whose primary purpose i… Show full official titleShow less

Official title: To amend subsection (q) of section 505 of the Federal Food, Drug, and Cosmetic Act to clarify the process for denying certain petitions whose primary purpose is to delay the approval of an application submitted under subsection (b)(2) or (j) of such section 505, and for other purposes.

Introduced: April 26, 2021 See on congress.gov
Health Administrative remediesCongressional oversightFood and Drug Administration (FDA)Government information and archivesPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 27, 2021
Referred to the Subcommittee on Health.
Apr 26, 2021
Referred to the House Committee on Energy and Commerce.
Apr 26, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 27, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon Act of 2021 or the STOP GAMES Act of 2021

This bill specifies factors that the Food and Drug Administration (FDA) must use in determining if a petition is submitted with the primary purpose of delaying the approval of a pending new or generic drug application. (Current law allows third parties, including interested parties, to file petitions asking the FDA to take various actions, such as to consider certain issues pertaining to an application for market approval for a drug; current law also allows the FDA to deny a petition that is submitted with the primary purpose of delaying approval of an application.)

The factors include (1) whether the petitioner filed serial petitions raising issues that could have been known to the petitioner when an earlier petition was filed, and (2) whether the petition has any data or information to support its scientific positions.

If the FDA finds that delay is the primary purpose of the petition, it must refer the matter to the Federal Trade Commission.

A party filing a petition must do so within 60 days of when the party first learned of the information on which the petition is based.

 Related & companion bills 1
  • HR 2387 Reintroduction of STOP GAMES Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2843: STOP GAMES Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2843/
MLA
"H.R. 2843: STOP GAMES Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2843/.
Bluebook (legal)
H.R. 2843, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2843/.
Markdown link
[H.R. 2843: STOP GAMES Act of 2021](https://openamerica.io/bill/117-HR-2843/)
Report a problem